ClinicalTrialsFinder

MYC Gene Rearrangement Clinical Trials in Nanjing, Jiangsu

1 recruitingNanjing, Jiangsu, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement

DLBCLUntreatedMYC Gene Rearrangement
The First Affiliated Hospital with Nanjing Medical University81 enrolled1 locationNCT04432714